December 8, 2016 / 9:15 PM / 8 months ago

BRIEF-Positive trends seen with latest study of Biogen Alzheimer's drug

Dec 8 (Reuters) - Data from small study of Biogen Alzheimer's drug:

* Show gradually increased doses of aducanumab associated with lower risk of brain swelling, compared with swelling seen in prior trials using fixed doses of the drug.

* Show experimental Alzheimer's drug signicantly reduces brain amyloid plaque, compared with placebo.

* Study involved patients with either mild or pre-symptomatic Alzheimer's

* Study shows that slowing of cognitive decline was similar to decline seen in earlier trials involving fixed drug doses

* Further company coverage: (Reporting by Ransdell Pierson)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below